AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31873859 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 169
Study 30668332 — intervention group
Group type: EXPERIMENTAL
Intervention: Wu chu yu tang (WCYT) 3.0 g three times per day for 4 weeks
Number of subjects: 90
Study 30668332 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole 20 mg once per day and WCYT placebo (3.0 g) three times per day for 4 weeks
Number of subjects: 90
Study 27365318 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based, individually tailored smoking cessation program (the Coach)
Number of subjects: 1120
Study 27365318 — intervention group
Group type: COMPARATOR
Intervention: Control group (comprehensive Internet smoking cessation website only)
Number of subjects: 1120
Study 25824001 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus plus octreotide LAR
Number of subjects: 429
Study 25824001 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus octreotide LAR
Number of subjects: 429
Study 23245537 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline or Bupropion for 8 weeks
Number of subjects: 18
Study 23245537 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (no treatment)
Number of subjects: 18
Study 21092939 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Exercises (CE)
Number of subjects: 39
Study 21092939 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Package (Cogpack)
Number of subjects: 39
Study 19460102 — intervention group
Group type: EXPERIMENTAL
Intervention: L-NAME (180 microg kg(−1)h(−1))
Number of subjects: 7
Study 19460102 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 7
Study 19460102 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperglycaemia
Number of subjects: 7
Study 17310385 — intervention group
Group type: EXPERIMENTAL
Intervention: Reboxetine (4 mg/day)
Number of subjects: 59
Study 17310385 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 15277911 — intervention group
Group type: COMPARATOR
Intervention: SEVO all group
Number of subjects: 200
Study 15277911 — intervention group
Group type: COMPARATOR
Intervention: SEVO pre group
Number of subjects: 200
Study 15277911 — intervention group
Group type: COMPARATOR
Intervention: SEVO post group
Number of subjects: 200
Study 15277911 — intervention group
Group type: COMPARATOR
Intervention: propofol group
Number of subjects: 200
Study 11357068 — intervention group
Group type: EXPERIMENTAL
Intervention: Secure(2) Medical Adhesive
Number of subjects: 21
Study 11357068 — intervention group
Group type: EXPERIMENTAL
Intervention: Secure(2) Medical Adhesive (reapplication)
Number of subjects: 21
Study 9202557 — intervention group
Group type: EXPERIMENTAL
Intervention: High-energy transurethral microwave thermotherapy (TUMT)
Number of subjects: 30
Study 7886584 — intervention group
Group type: EXPERIMENTAL
Intervention: Norplant users for more than 2 years
Number of subjects: 92
Study 7886584 — intervention group
Group type: COMPARATOR
Intervention: Control group (25 female blood donors)
Number of subjects: 92
Study 7886584 — intervention group
Group type: EXPERIMENTAL
Intervention: Norplant users for 5 years
Number of subjects: 92
Study 2878034 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-operative parenteral gentamicin and vancomycin (with streptomycin in the irrigating solution)
Number of subjects: 148
Study 2878034 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study 29294963 — intervention group
Group type: EXPERIMENTAL
Intervention: Male-perpetrated aggression (severe and non-severe)
Number of subjects: 562
Study 29294963 — intervention group
Group type: EXPERIMENTAL
Intervention: Bystander intervention in cases of male-perpetrated aggression
Number of subjects: 562
Study 29294963 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative responses regarding aggression
Number of subjects: 562
Study 29294963 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative responses regarding bystander intervention
Number of subjects: 562
Study 30845949 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Integrator with monthly health coaching sessions
Number of subjects: 209
Study 30845949 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Integrator only
Number of subjects: 209
Study 30845949 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 209
Study 26600170 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual art production
Number of subjects: 113
Study 26600170 — intervention group
Group type: COMPARATOR
Intervention: Cognitive art evaluation
Number of subjects: 113
Study 25803348 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral corticosteroids combined with antibiotics
Number of subjects: 0
Study 25803348 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral corticosteroids as monotherapy
Number of subjects: 0
Study 25803348 — intervention group
Group type: COMPARATOR
Intervention: Antibiotics alone
Number of subjects: 0
Study 23643289 — intervention group
Group type: COMPARATOR
Intervention: Healthy feet
Number of subjects: 44
Study 23643289 — intervention group
Group type: EXPERIMENTAL
Intervention: Flatfoot deformity
Number of subjects: 44
Study 22139679 — intervention group
Group type: EXPERIMENTAL
Intervention: SHINBARO (purified extract from a mixture of 6 oriental herbs)
Number of subjects: 0
Study 22139679 — intervention group
Group type: COMPARATOR
Intervention: Celecoxib (selective COX-2 inhibitor)
Number of subjects: 0
Study 19880473 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-initiated care (experimental group)
Number of subjects: 103
Study 19880473 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 103
Study 16813532 — intervention group
Group type: EXPERIMENTAL
Intervention: Strontium ranelate
Number of subjects: 1488
Study 15625331 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary-artery revascularization before surgery
Number of subjects: 510
Study 15625331 — intervention group
Group type: COMPARATOR
Intervention: No revascularization before surgery
Number of subjects: 510
Study 10752936 — intervention group
Group type: EXPERIMENTAL
Intervention: NEI‐VFQ (National Eye Institute Visual Function Questionnaire)
Number of subjects: 244
Study 10752936 — intervention group
Group type: EXPERIMENTAL
Intervention: NEI‐VFQ subscales
Number of subjects: 244
Study 8883754 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal gemeprost pessaries every 3 hours
Number of subjects: 0
Study 8883754 — intervention group
Group type: COMPARATOR
Intervention: Vaginal gemeprost pessaries every 6 hours
Number of subjects: 0
Study 1556674 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 1200 mg/day
Number of subjects: 45
Study 1556674 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 2400 mg/day
Number of subjects: 45
Study 1556674 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (both doses)
Number of subjects: 45
Study 3920599 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinoril (Sulindac sulphoxide)
Number of subjects: 20
Study 3920599 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 3432173 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine hydrochloride (90 mg/day)
Number of subjects: 39
Study 3432173 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine (40 mg/day)
Number of subjects: 39
Study 31995262 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based treatment (FBT)
Number of subjects: 107
Study 31295199 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional hearing aids using wide dynamic range compression
Number of subjects: 114
Study 31295199 — intervention group
Group type: EXPERIMENTAL
Intervention: Hearing aids with frequency translation
Number of subjects: 114
Study 31295199 — intervention group
Group type: EXPERIMENTAL
Intervention: Hearing aids with linear frequency transposition
Number of subjects: 114
Study 28990651 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIT) - three exercise sessions per week for 4 weeks, with weekly maintenance sessions if surgery was delayed.
Number of subjects: 53
Study 28990651 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 53
Study 28990651 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIT).
Number of subjects: 53
Study 28990651 — intervention group
Group type: COMPARATOR
Intervention: High-Intensity Interval Training (HIT) and Usual care (control).
Number of subjects: 53
Study 26149712 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomalidomide plus low-dose dexamethasone (POM + LoDEX)
Number of subjects: 455
Study 26149712 — intervention group
Group type: COMPARATOR
Intervention: High-dose dexamethasone (HiDEX)
Number of subjects: 455
Study 23316791 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional treatment plus whole body vibration (WBV) during supervised physical therapy
Number of subjects: 60
Study 23316791 — intervention group
Group type: COMPARATOR
Intervention: Functional treatment (control group)
Number of subjects: 60
Study 23316791 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional treatment plus WBV
Number of subjects: 60
Study 21644804 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual treatment
Number of subjects: 0
Study 21644804 — intervention group
Group type: COMPARATOR
Intervention: Conjoint treatment
Number of subjects: 0
Study 21644804 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice of treatment modality
Number of subjects: 0
Study 17682943 — intervention group
Group type: EXPERIMENTAL
Intervention: Nizatidine 150 mg twice daily
Number of subjects: 16
Study 17682943 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 17072690 — intervention group
Group type: EXPERIMENTAL
Intervention: ACOMA new circle
Number of subjects: 82
Study 17072690 — intervention group
Group type: COMPARATOR
Intervention: ACOMA conventional circle
Number of subjects: 82
Study 17072690 — intervention group
Group type: EXPERIMENTAL
Intervention: Fabius new circle
Number of subjects: 82
Study 17072690 — intervention group
Group type: COMPARATOR
Intervention: Fabius conventional circle
Number of subjects: 82
Study 17072690 — intervention group
Group type: COMPARATOR
Intervention: NM-GS
Number of subjects: 82
Study 14592564 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma adiponectin level in CAD group
Number of subjects: 99
Study 14592564 — intervention group
Group type: COMPARATOR
Intervention: Plasma adiponectin level in control group
Number of subjects: 99
Study 14592564 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of plasma adiponectin with creatinine in CAD group
Number of subjects: 99
Study 14592564 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of plasma adiponectin with HDL cholesterol in CAD group
Number of subjects: 99
Study 14592564 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of plasma adiponectin with BMI in CAD group
Number of subjects: 99
Study 14592564 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of plasma adiponectin with glucose in CAD group
Number of subjects: 99
Study 14592564 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of plasma adiponectin with triglycerides in CAD group
Number of subjects: 99
Study 14592564 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression model for adiponectin concentration
Number of subjects: 99
Study 11021553 — intervention group
Group type: EXPERIMENTAL
Intervention: 750 rads of intraoperative beta radiation (group 1)
Number of subjects: 65
Study 11021553 — intervention group
Group type: COMPARATOR
Intervention: No supplementation (group 2)
Number of subjects: 65
Study 9113222 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol consumption
Number of subjects: 0
Study 9113222 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 1606994 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone 200 mg daily
Number of subjects: 6
Study 1606994 — intervention group
Group type: COMPARATOR
Intervention: Digoxin 0.5 to 1 mg.d‐1 p.o. for 6 days
Number of subjects: 6
Study 3891005 — intervention group
Group type: EXPERIMENTAL
Intervention: Latex catheters
Number of subjects: 100
Study 3891005 — intervention group
Group type: COMPARATOR
Intervention: Silicone catheters
Number of subjects: 100
Study 31560372 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Lefamulin (600 mg every 12 hours for 5 days)
Number of subjects: 738
Study 31560372 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin (400 mg every 24 hours for 7 days)
Number of subjects: 738
Study 31560372 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Lefamulin
Number of subjects: 738
Study 31560372 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin
Number of subjects: 738
Study 28054374 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 471
Study 28054374 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 471
Study 26481772 — intervention group
Group type: EXPERIMENTAL
Intervention: Video version of the web-based computer-tailored intervention
Number of subjects: 1419
Study 26481772 — intervention group
Group type: EXPERIMENTAL
Intervention: Text version of the web-based computer-tailored intervention
Number of subjects: 1419
Study 26481772 — intervention group
Group type: COMPARATOR
Intervention: Control condition (not specified in detail)
Number of subjects: 1419
Study 26481772 — intervention group
Group type: EXPERIMENTAL
Intervention: Video version
Number of subjects: 1419
Study 24238113 — intervention group
Group type: EXPERIMENTAL
Intervention: Stapedoplasty
Number of subjects: 70
Study 24238113 — intervention group
Group type: EXPERIMENTAL
Intervention: Myringoplasty
Number of subjects: 70
Study 24238113 — intervention group
Group type: EXPERIMENTAL
Intervention: Type II tympanoplasty
Number of subjects: 70
Study 24238113 — intervention group
Group type: EXPERIMENTAL
Intervention: Type III tympanoplasty
Number of subjects: 70
Study 21537360 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive behavioral treatment (ICBT)
Number of subjects: 195
Study 21537360 — intervention group
Group type: COMPARATOR
Intervention: Internet-delivered stress management (ISM)
Number of subjects: 195
Study 19229451 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation and thermal-tactile stimulation
Number of subjects: 36
Study 19229451 — intervention group
Group type: COMPARATOR
Intervention: Thermal-tactile stimulation
Number of subjects: 36
Study 17346596 — intervention group
Group type: EXPERIMENTAL
Intervention: Transbond XT (light-cured bonding system)
Number of subjects: 120
Study 17346596 — intervention group
Group type: EXPERIMENTAL
Intervention: BisCover (polymeric resin polish) applied before bonding with Transbond XT
Number of subjects: 120
Study 17346596 — intervention group
Group type: COMPARATOR
Intervention: Blood contamination on acid-etched surfaces
Number of subjects: 120
Study 17346596 — intervention group
Group type: COMPARATOR
Intervention: Saliva contamination on acid-etched surfaces
Number of subjects: 120
Study 14982537 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (curriculum programme with harm minimization goal)
Number of subjects: 2300
Study 14982537 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 2300
Study 14982537 — intervention group
Group type: COMPARATOR
Intervention: Control group (comparison students)
Number of subjects: 2300
Study 12520749 — intervention group
Group type: EXPERIMENTAL
Intervention: NP regimen (vinorelbine + cisplatin); vinorelbine: 25 mg/m2 on days 1 and 8, cisplatin: 35 mg/m2 on days 1-3
Number of subjects: 110
Study 12520749 — intervention group
Group type: COMPARATOR
Intervention: MVP regimen (mitomycin + vindesine + cisplatin); mitomycin: 6 mg/m2 on day 1, vindesine: 3 mg/m2 on days 1 and 8, cisplatin: 30 mg/m2 on days 1-3
Number of subjects: 110
Study 9567231 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal manipulative therapy
Number of subjects: 20
Study 9567231 — intervention group
Group type: COMPARATOR
Intervention: Control (not explicitly mentioned)
Number of subjects: 20
Study 7897422 — intervention group
Group type: EXPERIMENTAL
Intervention: 240 mg/day ginkgolide B
Number of subjects: 104
Study 7897422 — intervention group
Group type: EXPERIMENTAL
Intervention: 360 mg/day ginkgolide B
Number of subjects: 104
Study 7897422 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study 2522789 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxacurium 30 micrograms kg‐1
Number of subjects: 27
Study 2522789 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxacurium 50 micrograms kg‐1
Number of subjects: 27
Study 2522789 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxacurium
Number of subjects: 27
Study 355966 — intervention group
Group type: EXPERIMENTAL
Intervention: Betamethasone-17-benzoate
Number of subjects: 0
Study 355966 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 30852431 — intervention group
Group type: EXPERIMENTAL
Intervention: Social Cognition and Interaction Training (SCIT)
Number of subjects: 74
Study 30852431 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation (Control)
Number of subjects: 74
Study 28572066 — intervention group
Group type: EXPERIMENTAL
Intervention: Snack food exposure
Number of subjects: 0
Study 28572066 — intervention group
Group type: COMPARATOR
Intervention: Control exposure
Number of subjects: 0
Study 26446653 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromfenac 0.1%
Number of subjects: 91
Study 26446653 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac 0.45%
Number of subjects: 91
Study 26446653 — intervention group
Group type: COMPARATOR
Intervention: Topical steroid only (Control)
Number of subjects: 91
Study 22869103 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir (twice-daily)
Number of subjects: 3381
Study 22869103 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3381
Study 21893708 — intervention group
Group type: EXPERIMENTAL
Intervention: Tele-rehabilitation programme
Number of subjects: 0
Study 21893708 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-distance technology
Number of subjects: 0
Study 19838489 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea (Camellia sinensis) 250 mg capsules
Number of subjects: 33
Study 19838489 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 17309331 — intervention group
Group type: EXPERIMENTAL
Intervention: G17DT (Gastrimmune)
Number of subjects: 0
Study 17309331 — intervention group
Group type: EXPERIMENTAL
Intervention: G17DT in combination with gemcitabine
Number of subjects: 0
Study 17309331 — intervention group
Group type: COMPARATOR
Intervention: Placebo and gemcitabine
Number of subjects: 0
Study 15562912 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified surgical technique with acellular dermal matrix graft (ADMG)
Number of subjects: 32
Study 15562912 — intervention group
Group type: COMPARATOR
Intervention: Subepithelial connective tissue graft (SCTG)
Number of subjects: 32
Study 11340898 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel therapy
Number of subjects: 0
Study 11340898 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel
Number of subjects: 0
Study 11340898 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel plus cisplatin
Number of subjects: 0
Study 11340898 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel plus gemcitabine
Number of subjects: 0
Study 11340898 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-drug regimens including docetaxel
Number of subjects: 0
Study 10036460 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing practice model based on Aristotelian theory and Rogers' science; specific dosage and duration not mentioned.
Number of subjects: 0
Study 8161002 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine (15 micrograms/kg)
Number of subjects: 6
Study 8161002 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycopyrrolate (8 micrograms/kg)
Number of subjects: 6
Study 8161002 — intervention group
Group type: EXPERIMENTAL
Intervention: Scopolamine (8 micrograms/kg)
Number of subjects: 6
Study 8161002 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 30018942 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed therapeutic ultrasound (PUS) administered 2 times weekly for 6 weeks
Number of subjects: 50
Study 30018942 — intervention group
Group type: COMPARATOR
Intervention: Kneading massage (KM) administered 2 times weekly for 6 weeks
Number of subjects: 50
Study 30018942 — intervention group
Group type: COMPARATOR
Intervention: Comparison of PUS and KM
Number of subjects: 50
Study 28827268 — intervention group
Group type: EXPERIMENTAL
Intervention: Running shoe model with 35% difference in cushioning properties (stiffness)
Number of subjects: 800
Study 28827268 — intervention group
Group type: COMPARATOR
Intervention: Running shoe model with standard cushioning properties
Number of subjects: 800
Study 26636511 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway (LMA) ventilation
Number of subjects: 90
Study 26636511 — intervention group
Group type: COMPARATOR
Intervention: Face Mask (FM) ventilation
Number of subjects: 90
Study 23076403 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced external counterpulsation (EECP)
Number of subjects: 18
Study 23076403 — intervention group
Group type: COMPARATOR
Intervention: Sham EECP
Number of subjects: 18
Study 21947297 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad2/HIF‐1α/VP16 (2×10(9) viral particles)
Number of subjects: 289
Study 21947297 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad2/HIF‐1α/VP16 (2×10(10) viral particles)
Number of subjects: 289
Study 21947297 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad2/HIF‐1α/VP16 (2×10(11) viral particles)
Number of subjects: 289
Study 21947297 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 289
Study 18426851 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratracheal instillation of a mixture of 0.25 mg/kg of budesonide and 100.00 mg/kg of survanta, every 8 hours
Number of subjects: 116
Study 18426851 — intervention group
Group type: COMPARATOR
Intervention: Surfactant only (100 mg/kg of survanta), every 8 hours
Number of subjects: 116
Study 16490736 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery + chemotherapy (cisplatin 80 mg/m² on Day 1 and 5-fluorouracil 500 mg/m²/day on Days 1-5)
Number of subjects: 89
Study 16490736 — intervention group
Group type: COMPARATOR
Intervention: Surgery-alone
Number of subjects: 89